BIOMEA FUSION INC (BMEA)
US09077A1060 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to BMEA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 55.52. This target is 397.47% above the current price.
BMEA was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BMEA.
In the previous month the buy percentage consensus was at a similar level.
BMEA was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-02 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-04-01 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-06 | Truist Securities | Initiate | Buy |
| 2023-12-08 | Citigroup | Reiterate | Buy -> Buy |
| 2023-08-01 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-27 | ScotiaBank | Initiate | Sector Outperform |
| 2023-07-25 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-07-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-12 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-06-26 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-06-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-06-26 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-06-26 | Citigroup | Maintains | Buy -> Buy |
| 2023-06-26 | Jefferies | Downgrade | Buy -> Hold |
| 2023-06-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-18 | Citigroup | Maintains | Buy -> Buy |
| 2023-05-12 | Barclays | Initiate | Overweight |
| 2023-05-04 | EF Hutton | Reiterate | Buy |
| 2023-05-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-19 | HC Wainwright & Co. | Maintains | Buy |
| 2023-04-11 | Oppenheimer | Reiterate | Outperform |
| 2023-04-06 | EF Hutton | Reiterate | Buy |
| 2023-03-29 | Oppenheimer | Maintains | Outperform |
| 2023-03-29 | Citigroup | Maintains | Buy |
| 2023-03-29 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-28 | EF Hutton | Maintains | Buy |